OGDEN, Utah, March 27 /PRNewswire-FirstCall/ -- Computerized Thermal Imaging, Inc. (CTI) (OTC:COIB) (BULLETIN BOARD: COIB) , today announced placement of CTI medical equipment at University of New England's (UNE) Biomechanics Research Laboratory. UNE believes biomechanical and physiological response to nerve injury and neural provocation research will be receiving critical and valuable physiological data generated from CTI's unique digital infrared imaging camera. UNE, located in Portland, ME, has contracted for the use of one imaging suite from CTI consisting of one Thermal Imaging Processor (TIP(TM)) to be implemented as a key component used for studies on Peripheral Nerve Injuries. The TIP(TM) system provides medical professionals a physiological view of the body, verses the anatomical view produced by other imaging modalities, such as x-ray and MRI. CTI understands UNE researchers plan to leverage CTI's most sensitive radiometric infrared camera commercially available to quantify changes in blood flow during physical therapy treatment of peripheral nerve injuries. By measuring temperature changes, TIP(TM) provides valuable images and data analysis allowing UNE researchers immediate, real-time feed-back. CTI is scheduled to install and train UNE's staff beginning April 3, 2006. UNE will commence its research immediately following the installation. A spokesman for CTI commented "CTI is excited to be working with and providing technologies for UNE's upcoming Peripheral Nerve Injury study. These kinds of opportunities enable CTI to contribute to the advancement of medical understanding and ultimately the development of treatments for physiological ailments." Dr. Nancy Quick, Director of UNE's Biomedical Laboratories, stated "the CTI thermal imaging system will provide an innovative and effective manner of examining physiological changes that occur during the application of various physical therapy techniques used to treat nerve injuries." She further commented by saying, "information gained from this work will provide a framework for enhancing outcomes in the treatment of these disorders." About Computerized Thermal Imaging, Inc. (TM) Computerized Thermal Imaging Inc. is in business to improve the quality of life through the development and deployment of thermal INFRARED imaging and associated technologies. While CTI's infrared technology offers multiple existing and potential applications, its primary focus is in medical and industrial applications. CTI markets two FDA-cleared pain management products -- the Thermal Imaging Processor (TIP) and an infrared light therapy device called the Photonic Stimulator. For more information please contact Pam Bloedel at or . Additionally CTI can be reached at 801-776-4700. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are CTI's ability to continue as a going concern given its current financial condition, CTI's pending application before the FDA seeking pre-market approval of CTI's BCS 2100 breast imaging system, CTI's ability to raise additional capital to fund cash requirements for future operations and CTI's ability to continue as a going concern. In particular, careful consideration should be given to cautionary statements made in the various reports CTI has filed with the Securities and Exchange Commission. CTI undertakes no duty to update or revise these forward-looking statements. DATASOURCE: Computerized Thermal Imaging, Inc. CONTACT: Pam Bloedel of Computerized Thermal Imaging, Inc., +1-801-776-4700, or Web site: http://www.cti-net.com/

Copyright